[1] 李奕宏,孙禹.Chemerin与心血管疾病的相关性研究[J].微量元素与健康研究,2019,36(2):63-65. [2] Er LK,Hsu LA,Juang JJ,et al.Circuiating chemern levels,but not the RARRES2 polymorphisms,predict the long - term outcome of angiographically confirmed coronary artery disease[J].Int Mol Sci,2019,20(5):1174. [3] 李海霞,魏静,哈小琴.趋化素与代谢性疾病的研究现状[J].中国医药生物技术,2020,15(5):508-511. [4] 姚月,顾萍.脂肪因子Chemerin介导动脉粥样硬化性疾病作用机制的研究进展[J].江苏医药,2019,45(7):713-717. [5] 谭小林,杜东平,余晓凤,等.Chemerin与动脉粥样硬化和脑梗死关系的研究进展[J].广东医学,2019,40(23):3351-3353,3360. [6] 闫晓红,刘晓红,张贞美,等.不同冠状动脉病变支数冠心病患者血清Chemerin水平变化及其意义[J].山东医药,2019,59(7):63-65. [7] van der Vorst EPC,Mandl M,Müller M,et al.Hematopoietic chemR23 (chemerin receptor 23) fuels atherosclerosis by sustaining an M1 macrophage-phenotype and guidance of plasmacytoid dendritic cells to murine lesions-brief report[J].Arterioscler Thromb Vasc Biol,2019,39(4):685-693. [8] 熊玮,董少红,张键,等.趋化素促进小鼠血管平滑肌细胞增殖的实验研究[J].临床心血管病杂志,2016,32(1):66-69. [9] Ferland DJ,Mullick AE,Watts SW.Chemerin as a driver of hypertension:a consideration.[J].American journal of hypertension,2020,33(11):975-986. [10] Wen J,Wang J,Guo L,et al.Chemerin stimulates aortic smooth muscle cell proliferation and migration via activation of autophagy in VSMCs of metabolic hypertension rats[J].Am Transl Res,2019,11(3):1327-1342. [11] 张福庄,陶红,陈波,等.肥胖合并动脉粥样硬化大鼠血管旁脂肪组织中趋化因子chemerin的表达变化[J].现代生物医学进展,2021,21(3):401-406. [12] Kutlay O,Kaygisiz,Kaygisiz B.The effect of chemerin on cardiac parameters and gene expressions in isolated perfused rat heart[J].Balkan Med,2019,36(1):43-48. [13] Zhang R,Liu S,Guo B,et al.Chemerin induces insulin resistance in rat cardiomyocytes in part through the ERK1/2 signaling pathway[J].Pharmacology,2014,94(5):259-264. [14] 朱丽雯,谭延振,张正斌,等.脂肪因子在心肌缺血再灌注损伤中的研究进展[J].中国体外循环杂志,2019,17(6):378-384. [15] 刘革铭,马洪俊,刘毅,等.心力衰竭的机制及诊疗的研究[J].医学信息,2022,35(10):91-94. [16] 熊晓昉,张磊,严政,等.脂肪因子chemerin对肥大的心肌细胞线粒体功能障碍的影响[J].中国病理生理杂志,2020,36(6):1122-1127. [17] Menzel J,di Giuseppe R,Biemann R,et al.Association between chemerin,omentin-1 and risk of heart failure in the population-based EPIC-Potsdam study[J].Sci Rep,2017,7(1):14171. [18] 马鸣飞,张春晓,刘燕,等.慢性心力衰竭患者血清趋化素水平变化及临床意义[J].中国循证心血管医学杂志,2019,11(4):458-461. [19] 史宝燕,孙洪胜,李玥,等.心房颤动的机制与代谢组学研究[J].中国比较医学杂志,2022,32(5):128-131,137. [20] 杨华,孟利民,信栓力,等.心房颤动患者血清趋化素水平与心房纤维化程度的相关性[J].临床荟萃,2020,35(3):206-210.
2023, Vol. 29 
冀公网安备13080202000677号